The feasibility of procalcitonin and CPIS score to reduce inappropriate antibiotics use among severe-critically ill COVID-19 pneumonia patients: A pilot study

Antibiotics have been extensively used in COVID-19 patients without a clear indication. We conducted a study to evaluate the feasibility of procalcitonin along with the “Clinical Pulmonary for Infection Score” (CPIS) as a strategy to reduce inappropriate antibiotic use. Using procalcitonin and CPIS...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathitakorn, Ornnicha, Jantarathaneewat, Kittiya, Weber, David J., Warren, David K., Nanthapisal, Sira, Rutjanawech, Sasinuch, Apisarnthanarak, Piyaporn, Apisarnthanarak, Anucha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837478/
https://www.ncbi.nlm.nih.gov/pubmed/35158008
http://dx.doi.org/10.1016/j.ajic.2022.01.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837478/
https://www.ncbi.nlm.nih.gov/pubmed/35158008
http://dx.doi.org/10.1016/j.ajic.2022.01.030

Ejemplares similares